IKBKE
Inhibitor of nuclear factor kappa-B kinase subunit epsilon
Also known as: IKK-i, IKKE, IKKE_HUMAN, KIAA0151
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14164
- Gene
- IKBKE
- Ensembl
- ENSG00000263528
- Chromosome
- 1
- Canonical length
- 716 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
IKBKE is a noncanonical I-kappa-B (see MIM 164008) kinase (IKK) that is essential for regulating antiviral signaling pathways. IKBKE has also been identified as a breast cancer (MIM 114480) oncogene and is amplified and overexpressed in over 30% of breast carcinomas and breast cancer cell lines (Hutti et al., 2009 [PubMed 19481526]).[supplied by OMIM, Oct 2009]
Canonical amino-acid sequenceUniProt
716 residues, UniProt reviewed canonical sequence.
>Q14164|IKBKE
1 MQSTANYLWH TDDLLGQGAT ASVYKARNKK SGELVAVKVF NTTSYLRPRE VQVREFEVLR
61 KLNHQNIVKL FAVEETGGSR QKVLVMEYCS SGSLLSVLES PENAFGLPED EFLVVLRCVV
121 AGMNHLRENG IVHRDIKPGN IMRLVGEEGQ SIYKLTDFGA ARELDDDEKF VSVYGTEEYL
181 HPDMYERAVL RKPQQKAFGV TVDLWSIGVT LYHAATGSLP FIPFGGPRRN KEIMYRITTE
241 KPAGAIAGAQ RRENGPLEWS YTLPITCQLS LGLQSQLVPI LANILEVEQA KCWGFDQFFA
301 ETSDILQRVV VHVFSLSQAV LHHIYIHAHN TIAIFQEAVH KQTSVAPRHQ EYLFEGHLCV
361 LEPSVSAQHI AHTTASSPLT LFSTAIPKGL AFRDPALDVP KFVPKVDLQA DYNTAKGVLG
421 AGYQALRLAR ALLDGQELMF RGLHWVMEVL QATCRRTLEV ARTSLLYLSS SLGTERFSSV
481 AGTPEIQELK AAAELRSRLR TLAEVLSRCS QNITETQESL SSLNRELVKS RDQVHEDRSI
541 QQIQCCLDKM NFIYKQFKKS RMRPGLGYNE EQIHKLDKVN FSHLAKRLLQ VFQEECVQKY
601 QASLVTHGKR MRVVHETRNH LRLVGCSVAA CNTEAQGVQE SLSKLLEELS HQLLQDRAKG
661 AQASPPPIAP YPSPTRKDLL LHMQELCEGM KLLASDLLDN NRIIERLNRV PAPPDVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IKBKE can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 23 nTPM
- tonsil: 19 nTPM
- appendix: 16 nTPM
- thymus: 15 nTPM
- skin: 14 nTPM
- esophagus: 14 nTPM
Single-cell type
- esophageal suprabasal cells: 48 nCPM
- foveolar cells: 28 nCPM
- esophageal basal cells: 27 nCPM
- paneth cells: 27 nCPM
- monocytes: 26 nCPM
- t-cells: 24 nCPM
Immune cell
- T-reg: 53 nTPM
- classical monocyte: 33 nTPM
- memory CD4 T-cell: 33 nTPM
- memory CD8 T-cell: 30 nTPM
- total PBMC: 29 nTPM
- naive CD8 T-cell: 27 nTPM
Brain region
- white matter: 9.5 nTPM
- basal ganglia: 9.3 nTPM
- thalamus: 9.2 nTPM
- medulla oblongata: 8.4 nTPM
- pons: 8.3 nTPM
- midbrain: 7.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 2.08
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation of innate immune response
- cellular response to virus
- defense response to virus
- gene expression
- immune response
- interleukin-17-mediated signaling pathway
- intrinsic apoptotic signaling pathway in response to DNA damage
- mRNA stabilization
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of lipid storage
- positive regulation of type I interferon production
- positive regulation of type I interferon-mediated signaling pathway
- regulation of protein-containing complex assembly
- response to interferon-beta
- type I interferon-mediated signaling pathway
Molecular functions
- ATP binding
- identical protein binding
- IkappaB kinase activity
- K48-linked polyubiquitin modification-dependent protein binding
- protein phosphatase binding
- protein serine/threonine kinase activity
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Protein kinase-like domain superfamily
- Protein kinase, ATP binding site
- TANK binding kinase 1, ubiquitin-like domain
- TANK-binding kinase 1, coiled-coil domain 1
- Inhibitor of nuclear factor kappa-B kinase
- Protein kinase domain
- TANK-binding kinase 1 coiled-coil domain 1
- TANK binding kinase 1 ubiquitin-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IKBKE in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IKBKE as an antibody target. Whether an autoantibody or antibody against IKBKE could matter depends on whether native IKBKE is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IKBKE is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IKBKE as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...